Ad-hoc | 12 August 2003 07:31

Carl Zeiss Meditec AG english

22.9 per cent boost in sales, despite strong euro Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– 22.9 per cent boost in sales, despite strong euro In the first nine months of the financial year 2002/2003, Carl Zeiss Meditec AG stepped up its sales revenues by 22.9% to EUR 175.9m (previous year: EUR 143.1m). On the basis of constant exchange rates compared to the previous year, sales would have increased by 37.0% to EUR 196.0m. Operating income (EBIT) amounted to EUR 19.3m (previous year: EUR 9.6m) Carl Zeiss Meditec also profited from the sale of the Aesthetic and Dental business units, which were disposed of with effect from 1 May 2003. The consolidated net income is shown split up according to US GAAP, i.e. income from continuing activities (core business in ophthalmology) and discontinued activities (Aesthetic and Dental). In the first nine months consolidated net income grew by 5.3% to EUR 4.7m (previous year: EUR 4.5m). Net income from continuing activities in the nine-month period amounted to EUR 7.8m, net income from discontinued activities was EUR -3.1m. In the third quarter (April to June) sales totalled EUR 55.4m (previous year: EUR 51.5m). This corresponds to an increase of 7.4% over the previous year. The EBIT adjusted for the Aesthetic and Dental business units rose by 22.5% to EUR 5.1m (previous year: EUR 4.1m). Gross margin improved to 42.9 % (previous year. 36.8%) in the first nine months. As of 30 June 2003 the equity ratio stood at 52.7% (30.09.02: 49.2%). The cash balance increased by 140.5% to EUR 17.3m (30.09.2002: EUR 7.2m). Operative cash flow almost tripled: In the reporting period it amounted to EUR 19.2m (previous year: EUR 6.8m). Carl Zeiss Meditec AG intends to carry out a capital increase this autumn in order to finance future growth. At the same time the free float will be increased. Contact: Carl Zeiss Meditec AG, Jens Brajer/Investor Relations, Goeschwitzer Str. 51-52, D-07745 Jena/Germany, Phone +49 (0)3641-220-105, Fax: +49 (0)3641-220-102, E- mail: investors@meditec.zeiss.com end of ad-hoc-announcement (c)DGAP 12.08.2003 ——————————————————————————– WKN: 531370; ISIN: DE0005313704; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart 120731 Aug 03